• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AZIYO BIOLOGICS INC. PROXICOR FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AZIYO BIOLOGICS INC. PROXICOR FOR CARDIAC TISSUE REPAIR; PATCH, PLEDGET, INTRACARDIAC - DXZ Back to Search Results
Model Number CMCV-120-404
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Type  Injury  
Manufacturer Narrative
Manufacturing review of the cormatrix ecm for cardiac tissue repair (now aziyo proxicor for cardiac tissue repair) device history record could not be completed as the lot/serial number was not provided.It is also noted that per the instructions for use (ifu - art-20700b) provided with the finished proxicor for cardiac tissue repair device, localized inflammation, patch dehiscence or rupture, or reformation of cardiac defect are listed as a potential complications associated with the procedure and device.In addition, the ifu for the proxicor for cardiac tissue repair device provides a warning/precaution that the device must be sutured to viable native tissue.Indicating that all edges of sutured ecm patch be made to viable tissue which would exclude leaving a "free-edge" to simulate the commissural closure of the valve cusps.Further, the ifu states under suggested instructions for implanting proxicor for cardiac tissue repair to "place the edge of the proxicor in contact with viable tissue." although the exact cause of the reported aortic insufficiency issue cannot be conclusively determined, localized inflammation, patch dehiscence or rupture, reformation of cardiac defect, are known complications associated with the use of a proxicor for cardiac tissue repair and this surgical implant procedure.Should aziyo receive any additional details related to this event, a supplemental report will be filed.
 
Event Description
As part of the post market surveillance process, this article / clinical case report published in xenotransplantation 2017;24:e12341 titled "congenital aortic valve repair using cormatrix: a histologic evaluation" was reviewed.This article reports a retrospective review of six (6) patients who underwent surgery for severe aortic valve stenosis (4 patients) or regurgitation (2 patients) between april and july 2013.Aortic valve repair was performed on all patients using decm cormatrix as a leaflet replacement or extension.This report is focused on patient #4 (per publication table 1: demographic and surgical details) where a (b)(6) yr.Old male with aortic insufficiency (grade 3) underwent a replacement of the right cusp, augmentation of the anterior cusp and left cusp shaving procedure using cormatrix (now aziyo biologics) decm (model #: unknown [likely to be proxicor for cardiac tissue repair], lot #: unknown) with the new cusp in contact to the aortic wall.Following operation patient demonstrated satisfactory results with grade 1 insufficiency and good mobility of the tissue observed at 1mo.At the 3 month follow-up, patient presented with grade 3 aortic insufficiency and reoperation performed on post-op day 122.Attempts to contact corresponding author have been unsuccessful for any additional information.Should any additional information be received a follow-up report will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROXICOR FOR CARDIAC TISSUE REPAIR
Type of Device
PATCH, PLEDGET, INTRACARDIAC - DXZ
Manufacturer (Section D)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer (Section G)
AZIYO BIOLOGICS INC.
1100 old ellis road
ste 1200
roswell GA 30076
Manufacturer Contact
michael hennick
1100 old ellis road
ste 1200
roswell, GA 30076
4705144023
MDR Report Key10680461
MDR Text Key211492294
Report Number3005619880-2020-00052
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
K063349
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature,study
Reporter Occupation Physician
Type of Report Initial
Report Date 10/14/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/14/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCMCV-120-404
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/08/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 YR
-
-